# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA1221916 | 30 | Phospholipidosis | 0 | ALA1227365 | Not Active | ||||||
2. | ALA1221915 | 29 | Phospholipidosis | 0 | ALA1227365 | Active | ||||||
3. | ALA1221913 | 27 | Phospholipidosis | 0 | ALA1227365 | Not Active | ||||||
4. | ALA1221852 | 26 | Phospholipidosis | 0 | ALA1227365 | Not Active | ||||||
5. | ALA1697854 | Zorubicin | Phospholipidosis | 0 | ALA1697855 | Negative: based on the absence of positive reported data from WMDD | ||||||
6. | Ziprasidone | ziprasidone | Phospholipidosis | 0 | ALA1697855 | Negative: based on the absence of positive reported data from WMDD | ||||||
7. | ALA37744 | 10 | Phospholipidosis | 0 | ALA1697855 | Positive: strong inducer confirmed by electron microscopy | ||||||
8. | 3′-Azido-3′-deoxythymidine | AZT | Phospholipidosis | 0 | ALA1697855 | Negative: confirmed by electron microscopy | ||||||
9. | α-Zearalanol Solution | Zeranol | Phospholipidosis | 0 | ALA1697855 | Negative: based on the absence of positive reported data from WMDD | ||||||
10. | ALA502135 | D-xylose | Phospholipidosis | 0 | ALA1697855 | Negative: based on the absence of positive reported data from WMDD | ||||||
11. | ALA1464 | 25 | Phospholipidosis | 0 | ALA1697855 | Negative: based on the absence of positive reported data from WMDD | ||||||
12. | ALA3085436 | 42 | Phospholipidosis | 0 | ALA1697855 | Negative: based on the absence of positive reported data from WMDD | ||||||
13. | ALA238071 | Vindesine | Phospholipidosis | 0 | ALA1697855 | Negative: based on the absence of positive reported data from WMDD | ||||||
14. | Vinblastine | Vinblastine | Phospholipidosis | 0 | ALA1697855 | Negative: confirmed by electron microscopy | ||||||
15. | D,L-Venlafaxine | Venlafaxine | Phospholipidosis | 0 | ALA1697855 | Negative: based on the absence of positive reported data from WMDD | ||||||
16. | Valpromide | Valpromide | Phospholipidosis | 0 | ALA1697855 | Negative: based on the absence of positive reported data from WMDD | ||||||
17. | 2-Propylvaleric acid | valproate | Phospholipidosis | 0 | ALA1697855 | Negative: confirmed by electron microscopy | ||||||
18. | ALA1615351 | trospectomycin sulfate | Phospholipidosis | 0 | ALA1697855 | Positive: strong inducer confirmed by electron microscopy | ||||||
19. | ALA408 | Troglitazone | Phospholipidosis | 0 | ALA1697855 | Negative: based on the absence of positive reported data from WMDD | ||||||
20. | Triprolidine | 7 (Triprolidine) | Phospholipidosis | 0 | ALA1697855 | Negative: based on the absence of positive reported data from WMDD |